Cortico-spinal pathways and inhibitory mechanisms in hepatic encephalopathy.

Transcranial magnetic stimulation of the cerebral cortex was used to study motor system function in 31 cirrhotics (29 post-necrotic and 2 cryptogenic) with and without hepatic encephalopathy (HE). The results were compared with those of 14 healthy subjects matched for age. A significant increase of central motor conduction time, a significant raising of the motor evoked potential (MEP) threshold at rest and a significant reduction of the MEP/muscle action potential (MAP) amplitude ratio were found only in patients with chronic stable (12 patients) and recurrent (9 patients) HE. Vice versa, a significant shortening of the central silent period was observed in all 31 cirrhotic patients. The peripheral silent period was normal in all instances. These results indicate that the damage to the cortico-spinal pathways is related to the progression of cirrhosis to HE, and that cirrhotic patients present a dysfunction of the inhibitory motor mechanisms before HE is clinically manifest.

[1]  E. Tolosa,et al.  Hyperintense globus pallidus on T1‐weighted MRI in cirrhotic patients is associated with severity of liver failure , 1993, Neurology.

[2]  R. Adams,et al.  Principles of Neurology , 1996 .

[3]  L. Pannell,et al.  Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. , 1991, The New England journal of medicine.

[4]  M. Morgan.  The treatment of chronic hepatic encephalopathy. , 1991, Hepato-gastroenterology.

[5]  S. Sherlock,et al.  The electroencephalograph in liver disease. , 1957, Lancet.

[6]  M Nordin,et al.  Motor-unit responses in human wrist flexor and extensor muscles to transcranial cortical stimuli. , 1987, Journal of neurophysiology.

[7]  A Berardelli,et al.  Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. , 1993, The Journal of physiology.

[8]  M Hallett,et al.  Transcranial magnetic stimulation. Negative effects. , 1995, Advances in neurology.

[9]  E. Hahn,et al.  Visual event-related P300 potentials in early portosystemic encephalopathy. , 1992, Gastroenterology.

[10]  A. Guidotti,et al.  Endogenous Benzodiazepine Receptor Ligands in Human and Animal Hepatic Encephalopathy , 1990, Journal of neurochemistry.

[11]  M. Kofler,et al.  Effect of the inhibitory phenomenon following magnetic stimulation of cortex on brainstem motor neuron excitability and on the cortical control of brainstem reflexes , 1993, Muscle & nerve.

[12]  J. Desmedt.  Motor control mechanisms in health and disease , 1983 .

[13]  V. Amassian,et al.  Physiological basis of motor effects of a transient stimulus to cerebral cortex. , 1987, Neurosurgery.

[14]  L. Larsson,et al.  Late muscular responses to transcranial cortical stimulation in man. , 1990, Electroencephalography and clinical neurophysiology.

[15]  M. Norenberg,et al.  Astrocytes in hepatic encephalopathy. , 1990, Advances in experimental medicine and biology.

[16]  H. R. Tyler,et al.  Studies in Asterixis Part I , 1964 .

[17]  P. Meier,et al.  Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. , 1989, Gastroenterology.

[18]  E. Messori,et al.  Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. , 1984, Gut.

[19]  J. Bircher,et al.  mechanism of the excessive sedative response of cirrhotics to benzodiazepines: Model experiments with triazolam , 1987, Hepatology.

[20]  J. Kulisevsky,et al.  MRI pallidal hyperintensity and brain atrophy in cirrhotic patients , 1993, Neurology.

[21]  P. Ferenci,et al.  Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. , 1989, Gastroenterology.

[22]  N Accornero,et al.  Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. , 1994, Brain : a journal of neurology.

[23]  W. Raabe,et al.  Synaptic transmission in ammonia intoxication. , 1987, Neurochemical pathology.

[24]  Brain indoles in human hepatic encephalopathy , 1993, Hepatology.

[25]  W. Mendelson,et al.  COULD AN ENDOGENOUS BENZODIAZEPINE LIGAND CONTRIBUTE TO HEPATIC ENCEPHALOPATHY? , 1988, The Lancet.

[26]  P. Rossini,et al.  'Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. , 1991, Electroencephalography and clinical neurophysiology.

[27]  M. Mehndiratta,et al.  Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. , 1990, The American journal of gastroenterology.

[28]  Stanley Fahn,et al.  Negative Motor Phenomena , 1995 .

[29]  M. Hallett,et al.  Spinal motor neuron excitability during the silent period after cortical stimulation. , 1991, Electroencephalography and clinical neurophysiology.

[30]  L. Pannell,et al.  Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[32]  M. Zeneroli,et al.  Interindividual variability of the number connection test. , 1992, Journal of hepatology.

[33]  M. H. Morgan,et al.  Intravenous administration of diazepam in patients with chronic liver disease. , 1976, Gut.

[34]  A T Barker,et al.  Magnetic stimulation of the human brain and peripheral nervous system: an introduction and the results of an initial clinical evaluation. , 1987, Neurosurgery.

[35]  C D Marsden,et al.  Direct electrical stimulation of corticospinal pathways through the intact scalp in human subjects. , 1983, Advances in neurology.

[36]  C. Madl,et al.  IMPROVEMENT OF HEPATIC ENCEPHALOPATHY TREATED WITH FLUMAZENIL , 1988, The Lancet.

[37]  L. Zieve.  Pathogenesis of hepatic encephalopathy , 1987, Metabolic Brain Disease.

[38]  M. Rowan,et al.  The auditory P300 event—related potential: An objective marker of the encephalopathy of chronic liver disease , 1990, Hepatology.

[39]  A. Berardelli,et al.  Electrical and magnetic transcranial stimulation in patients with corticospinal damage due to stroke or motor neurone disease. , 1991, Electroencephalography and clinical neurophysiology.

[40]  C D Marsden,et al.  Percutaneous electrical stimulation of corticospinal pathways at the level of the pyramidal decussation in humans , 1991, Annals of neurology.

[41]  W. Raabe.  Ammonium ions abolish excitatory synaptic transmission between cerebellar neurons in primary dissociated tissue culture. , 1992, Journal of neurophysiology.

[42]  R. Mutani,et al.  Parkinson's disease rigidity , 1991, Neurology.

[43]  S. Schenker,et al.  Portal systemic encephalopathy. , 1997, Clinics in liver disease.

[44]  S. Sherlock,et al.  Portal-systemic encephalopathy; neurological complications of liver disease. , 1954, Lancet.

[45]  P. Schönle,et al.  Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulation. , 1992, Electroencephalography and clinical neurophysiology.

[46]  H. Conn.  Current Diagnosis and Treatment of Hepatic Coma , 1973 .

[47]  A Berardelli,et al.  Electromyographic silent period after transcranial brain stimulation in huntington's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[48]  R. Mutani,et al.  Magnetic brain stimulation: the silent period after the motor evoked potential. , 1992, Neurology.

[49]  N. Chu,et al.  Brainstem auditory evoked potentials in hepatic encephalopathy , 1986, Hepatology.

[50]  N. Chu,et al.  Somatosensory evoked potentials in hepatic encephalopathy. , 1985, Gastroenterology.

[51]  R. Butterworth,et al.  Flumazenil in cirrhotic patients in hepatic coma: A randomized double‐blind placebo‐controlled crossover trial , 1994, Hepatology.